Leaflet DORNITE 25mg film-coated tablets

Indicated for: allergic rhinitis; urticaria

Route of administration: oral

Substance: doxylamine (antiallergic agent)

ATC: R06AA09 (Respiratory system | Antihistamines for systemic use | Aminoalkyl ethers)

Precautions:
Driving impairment
Driving impairment

This medicine may affect your ability to drive or use machines.

Glaucoma warning
Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Anticholinergic effects
Anticholinergic effects

May cause dry mouth, constipation, urinary retention, or blurred vision.

Drowsiness / sedation
Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Doxylamine is an antihistamine used for the short-term treatment of insomnia and for relieving allergic symptoms such as rhinitis or urticaria. It works by blocking H1 histamine receptors, producing a sedative effect.

The medication is taken orally, usually before bedtime, as directed by a doctor or the product leaflet.

Side effects may include drowsiness, dry mouth, dizziness, or constipation. In rare cases, severe allergic reactions or confusion may occur.

Doxylamine is not recommended for patients with hypersensitivity to this medication, closed-angle glaucoma, or urinary retention.

General data about DORNITE 25mg

  • Substance: doxylamine
  • Date of latest medicines list: 01-06-2019
  • Product code: W65611001
  • Concentration: 25mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 7
  • Product type: Generic medicine
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: KRKA, D.D., NOVO MESTO - SLOVENIA
  • Holder: KRKA, D.D., NOVO MESTO - SLOVENIA
  • Number: 11287/2018/01
  • Shelf life: 2 years